BioBridgeXAll companies

Lyell Immunopharma, Inc.

Pharmaceutical company · South San Francisco, California, United States · Nasdaq: LYEL

Lyell Immunopharma, Inc. is a pharmaceutical company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2018. Its shares trade on Nasdaq under the ticker LYEL. It has reported private securities offerings to the US SEC, most recently $493 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Lyell Immunopharma at a glance

Typepharmaceutical company
HeadquartersSouth San Francisco, California, United States
Earliest incorporation on record2018
Stock listingNasdaq: LYEL
SEC industryPharmaceutical Preparations
SEC CIK1806952

What does Lyell Immunopharma do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $493 million sold (2020).

Frequently asked questions about Lyell Immunopharma

Where is Lyell Immunopharma headquartered?

Lyell Immunopharma, Inc. is headquartered in South San Francisco, California, United States.

What does Lyell Immunopharma do?

Lyell Immunopharma, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Lyell Immunopharma a public company?

Yes. Lyell Immunopharma, Inc. trades on Nasdaq under the ticker LYEL.

When was Lyell Immunopharma founded?

The earliest incorporation on record for Lyell Immunopharma, Inc. is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.